LIP
TMDX icon

Liontrust Investment Partners’s Transmedics TMDX Stock Holding History

Liontrust Investment Partners’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-523,748
Closed -$70.2M – 206
2025
Q2 		$70.2M Sell
523,748
-30,609
-6% -$3.36M 1% 42
2025
Q1 		$37.3M Sell
554,357
-42,044
-7% -$2.89M 0.58% 43
2024
Q4 		$37.2M Buy
596,401
+565,258
+1,815% +$52.6M 0.54% 47
2024
Q3 		$4.69M Hold
31,143
– – 0.07% 124
2024
Q2 		$4.69M Sell
31,143
-231
-0.7% -$27.7K 0.07% 124
2024
Q1 		$2.32M Sell
31,374
-331
-1% -$27.3K 0.03% 144
2023
Q4 		$2.5M Buy
31,705
+26
+0.1% +$1.57K 0.04% 137
2023
Q3 		$1.73M Buy
+31,679
New +$2.28M 0.03% 144

Other funds holding TMDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Liontrust Investment Partners's TMDX Position: Q3 2025 in Review

Liontrust Investment Partners sold out of Transmedics (TMDX) in Q3 2025, closing a stake of 523,748 shares — an estimated $70.2M sold.

Liontrust Investment Partners first reported a position in TMDX in Q3 2023 and held it in 8 quarters. The position peaked at $70.2M in Q2 2025. 388 funds tracked by Wall St. Rank hold TMDX as of Q3 2025.

  • Liontrust Investment Partners reported no remaining Transmedics position as of Q3 2025 after selling out during the quarter.
  • Liontrust Investment Partners sold 523,748 Transmedics shares in Q3 2025, an estimated $70.2M.
  • Liontrust Investment Partners first reported a position in Transmedics in Q3 2023 and held it in 8 quarters.
  • Liontrust Investment Partners's Transmedics position peaked at $70.2M in Q2 2025.
  • 388 funds tracked by Wall St. Rank held Transmedics as of Q3 2025.

Based on Liontrust Investment Partners's 13F filing for Q3 2025, filed 24 Nov 2025.